Cancer News and Research

Latest Cancer News and Research

Viral toxin causes release of serotonin leading to vomiting

It is well known that viruses like rotavirus and norovirus are behind the majority of stomach infections. But it was unclear how vomiting developed, and the treatments available were oral fluid replacement and intravenous drips to prevent dehydration of the body.

18 Jul 2011

SEEK HIV-v vaccine demonstrates 90% reduction in HIV viral load

SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.

18 Jul 2011

Cancer rates increase among middle-aged people in Great Britain

CANCER rates in middle-aged men and women in Great Britain have gone up by nearly 20 per cent in a generation - an increase of 17,000 cases a year - according to new figures released today (Monday) by Cancer Research UK.

18 Jul 2011

Yukon, Canadian Cancer Society announce Kordyban Lodge construction

The ground adjacent to the University Hospital of Northern B.C. is no longer a parking lot. Today, the Canadian Cancer Society B.C. and Yukon together with local government representatives and supporters celebrated the start of construction on the Kordyban Lodge by breaking ground.

16 Jul 2011

Teva, Amgen settle G-CSF patent litigation

Amgen announced today that the United States (U.S.) District Court in Pennsylvania has entered final judgment and a permanent injunction against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA prohibiting them from infringing Amgen's patents relating to human G-CSF and methods for its use.

16 Jul 2011

Research: 17 genetic mutations linked to colon cancer formation

Researchers at UT Southwestern Medical Center say there are at least 70 genetic mutations involved in the formation of colon cancer, far more than scientists previously thought.

16 Jul 2011

Stored red blood cells lose ability to release key anti-adhesive molecule

Donated red blood cells lose a key feature that diminishes their lifesaving power the longer they have been stored, according to researchers at Duke University Medical Center.

16 Jul 2011

Champions Oncology revenue increases 41% to $6.9 million for fiscal 2011

For its fiscal year 2011, Champions generated revenue of $6.9 million, an increase of $2 million or 41%, compared to fiscal year 2010.

16 Jul 2011

FDA ODAC recommends approval of Seattle Genetics' ADCETRIS for Hodgkin lymphoma after ASCT

Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).

15 Jul 2011

Genome Research publishes studies utilizing emerging Collaborative Cross mouse strains

The Collaborative Cross represents a large collection of new inbred mouse strains created by the mouse genetics community aimed at revolutionizing the study of complex genetic traits and diseases. Derived from classical inbred strains and wild-derived strains, the CC captures nearly 90% of known genetic variation in laboratory mice, far surpassing more commonly used inbred strains.

15 Jul 2011

Methods and trends in evaluation of cancer risk

The development of almost all cancer is influenced by environmental factors, argues Dr Günter Obe and co-editors in their new title Cancer Risk Evaluation: Methods and Trends. However, while some environmental factors, such as smoking or ionizing radiation, puts the vast majority of humans at risk regardless of their genetic background, many other risk factors such as hazardous working conditions, increase the cancer risk for smaller groups of the population and are often dependent on additional factors as well as an individual's genetics.

15 Jul 2011

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of T cell immune responses of up to over two years (at the latest time measured) in 7 of 8 evaluated patients following a fourth vaccination of VGX-3100, its investigational SynCon® DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus (HPV) that is delivered using intramuscular electroporation.

15 Jul 2011

Experts available to discuss various effects of sun exposure

After many long winter months, Canadians are eager to get outside and enjoy the short and sweet season of warm summer sunshine. Although soaking up the sun can help us forget our winter blues, too much or unprotected exposure can have harmful consequences to your health.

15 Jul 2011

Patients with pulmonary hypertension more likely to have complications after bilateral TKA

A new study by researchers at Hospital for Special Surgery has identified patients who are at a higher risk of morbidity and mortality when undergoing knee replacement surgery in both legs at the same time.

15 Jul 2011

EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events

Amgen today announced that the European Commission (EC) has granted marketing authorization for XGEVA (denosumab) for the prevention of skeletal-related events (SREs) in adults with bone metastases from solid tumors.

15 Jul 2011

Novel combined technique for treating neoplastic meningitis, hydrocephalus

Approximately five to ten percent of patients with primary or metastatic cancer suffer from devastating neurological complications such as headaches, seizures, confusion, difficulty swallowing and visual disturbances. These deficits are caused by a life-threatening form of brain invasion from cancer called neoplastic meningitis.

15 Jul 2011

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.

15 Jul 2011

IBM, Coriell partner to explore personalized medicine

IBM today announced that Coriell Institute for Medical Research, the largest biobank of living human cells, is using IBM technology to advance its research of human genetic disease and to more efficiently maintain its massive collection of biological resources.

15 Jul 2011

ACS honors Cedars-Sinai surgeon with 17th annual Jacobson Innovation Award

George Berci, MD, FACS, has received the highest honor bestowed by the American College of Surgeons (ACS), with the largest, most prestigious surgical organization in the nation recognizing him as a pioneer who developed the endoscopic and laparoscopic techniques that provide the basis of all minimally invasive surgeries performed today.

15 Jul 2011

FDA asks Guided Therapeutics to provide additional information on LuViva PMA

Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.

15 Jul 2011

Cancer News and Research

Latest Cancer News and Research

Viral toxin causes release of serotonin leading to vomiting

SEEK HIV-v vaccine demonstrates 90% reduction in HIV viral load

Cancer rates increase among middle-aged people in Great Britain

Yukon, Canadian Cancer Society announce Kordyban Lodge construction

Teva, Amgen settle G-CSF patent litigation

Research: 17 genetic mutations linked to colon cancer formation

Stored red blood cells lose ability to release key anti-adhesive molecule

Champions Oncology revenue increases 41% to $6.9 million for fiscal 2011

FDA ODAC recommends approval of Seattle Genetics' ADCETRIS for Hodgkin lymphoma after ASCT

Genome Research publishes studies utilizing emerging Collaborative Cross mouse strains

Methods and trends in evaluation of cancer risk

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Experts available to discuss various effects of sun exposure

Patients with pulmonary hypertension more likely to have complications after bilateral TKA

EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events

Novel combined technique for treating neoplastic meningitis, hydrocephalus

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

IBM, Coriell partner to explore personalized medicine

ACS honors Cedars-Sinai surgeon with 17th annual Jacobson Innovation Award

FDA asks Guided Therapeutics to provide additional information on LuViva PMA

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in